Literature DB >> 16283626

Generation of a conditional allele of the B-myb gene.

Paloma García1, Oscar Berlanga, Roger Watson, Jon Frampton.   

Abstract

B-Myb is an essential transcription factor involved in control of the cell cycle and the regulation of tissue-specific gene expression in a wide range of cell types. Loss of both alleles results in early embryonic lethality at E4.5-6.5. To address the function of B-Myb in later stages of embryogenesis and in specific adult tissues, a floxed B-myb allele (B-mybF) was generated. Cre-mediated deletion in vivo was demonstrated by breeding with a transgenic GATA-Cre mouse line. An intermediate allele produced in the creation of the floxed allele, in which the PGK-neo(R) cassette is present in intron 3 (B-myb(loxneo)), was deduced to be a weak hypomorph based on the later embryonic death of homozygotes compared to B-myb(-/-) embryos. To demonstrate the efficiency and possible consequences of B-myb inactivation, we performed conditional deletion in cultured MEFs and observed decreased growth that correlated with aberrant nuclear DNA replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283626     DOI: 10.1002/gene.20170

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  11 in total

1.  B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development.

Authors:  Stacey J Baker; Avi Ma'ayan; Yen K Lieu; Premila John; M V Ramana Reddy; Edward Y Chen; Qiaonan Duan; Hans-Willem Snoeck; E Premkumar Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

2.  Analysis of mice lacking the heparin-binding splice isoform of platelet-derived growth factor A.

Authors:  Johanna Andrae; Hans Ehrencrona; Radiosa Gallini; Mark Lal; Hao Ding; Christer Betsholtz
Journal:  Mol Cell Biol       Date:  2013-08-12       Impact factor: 4.272

Review 3.  The DREAM complex: master coordinator of cell cycle-dependent gene expression.

Authors:  Subhashini Sadasivam; James A DeCaprio
Journal:  Nat Rev Cancer       Date:  2013-07-11       Impact factor: 60.716

4.  Myb proteins regulate expression of histone variant H2A.Z during thymocyte development.

Authors:  Joel Hooper; Diane Maurice; Mary J G Argent-Katwala; Kathleen Weston
Journal:  Immunology       Date:  2007-10-11       Impact factor: 7.397

5.  An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma.

Authors:  F Iltzsche; K Simon; S Stopp; G Pattschull; S Francke; P Wolter; S Hauser; D J Murphy; P Garcia; A Rosenwald; S Gaubatz
Journal:  Oncogene       Date:  2016-05-23       Impact factor: 9.867

6.  Mouse survival motor neuron alleles that mimic SMN2 splicing and are inducible rescue embryonic lethality early in development but not late.

Authors:  Suzan M Hammond; Rocky G Gogliotti; Vamshi Rao; Ariane Beauvais; Rashmi Kothary; Christine J DiDonato
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

7.  B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells.

Authors:  Maëlle Lorvellec; Stéphanie Dumon; Apolinar Maya-Mendoza; Dean Jackson; Jon Frampton; Paloma García
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

8.  MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia.

Authors:  M Clarke; S Dumon; C Ward; R Jäger; S Freeman; B Dawood; L Sheriff; M Lorvellec; R Kralovics; J Frampton; P García
Journal:  Leukemia       Date:  2012-08-22       Impact factor: 11.528

Review 9.  Novel Molecular Markers for Breast Cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Biomark Cancer       Date:  2016-03-13

10.  Fine-Tuning Mybl2 Is Required for Proper Mesenchymal-to-Epithelial Transition during Somatic Reprogramming.

Authors:  Carl Ward; Giacomo Volpe; Pierre Cauchy; Anetta Ptasinska; Ruba Almaghrabi; Daniel Blakemore; Monica Nafria; Doris Kestner; Jon Frampton; George Murphy; Yosef Buganim; Keisuke Kaji; Paloma García
Journal:  Cell Rep       Date:  2018-08-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.